In-vitro and Companion Diagnostics Industry - 2010 Yearbook - GBI Research Reports

In-vitro and Companion Diagnostics Industry - 2010 Yearbook

In-vitro and Companion Diagnostics Industry - 2010 Yearbook - GBI Research Reports
In-vitro and Companion Diagnostics Industry - 2010 Yearbook
Published Jan 21, 2011
173 pages — Published Jan 21, 2011
Price US$ 3,500.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

GBI Researchs report, In-vitro and Companion Diagnostics Industry- 2010 Yearbook provides key data, information and analysis on the global invitro diagnostic and companion diagnostics market. The report provides a market landscape, competitive landscape and market trends information on the following market categories: clinical chemistry, immunochemistry, hematology, histology and cytology, microbiology, infectious immunology, genetic testing and companion diagnostics. The report provides comprehensive information on the key trends affecting the aforementioned categories, and key analytical content on the market dynamics. The report also reviews the latest, advances in in-vitro diagnostics technology. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Researchs team of industry experts.

Scope

Its scope includes:
- Market revenue data from 2002 to 2009. Forecast revenue data to 2016. Company shares data for 2009.
- Market size and company share data for six diagnostic imaging market categories: clinical chemistry, immunochemistry, hematology, histology and cytology, microbiology, infectious immunology, genetic testing and companion diagnostics.
- Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain and Japan.
- Qualitative analysis of the key market trends, and market drivers and restraints, by each category within the diagnostic imaging market.
- The report also covers information on the leading market players, the competitive landscape, and the leading technologies.
- Key players covered include F.Hoffman-La Roche, Abbott Laboratories, bioMerieux, Beckman Coulter, Qiagen, Dako Denmark A/S, Siemens Medical Solutions.

Reasons to buy

The report will enhance your decision making capability. It will allow you to:
- Develop business strategies by understanding the trends and developments that are driving the diagnostic imaging market globally.
- Design and develop your product development, marketing and sales strategies.
- Exploit M&A opportunities by identifying market players with the most innovative pipelines.
- Develop market-entry and market expansion strategies.
- Identify key players best positioned to take advantage of emerging market opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying products most likely to ensure a robust return.
- Whats the next big thing in the diagnostic imaging market landscape? Identify, understand and capitalize.
- Make more informed business decisions from the insightful and in-depth analysis of the global diagnostic imaging market and the factors shaping it.

  
Source:
Document ID
GBIHC064MR
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents47
  List of Tables72
  List of Figures92
Global IVD and CDx Market: Introduction and Overview112
  In-vitro and Companion diagnostics111
    Overview111
  GBI Research Report Guidance121
Global IVD and CDx Market: Market Characterization1314
  Global IVD and CDx Market, Revenues ($m), 2002 2009132
  Global IVD and CDx Market, Revenue Forecasts ($m), 2009 2016152
  Global IVD and CDx Market, Key Company Shares (%), 2009171
  Global IVD and CDx Market: Key Market Trends181
    Entry of Diagnostic Imaging Players Into In Vitro Diagnostics Market has Set the Stage for New Technologies to be Developed by Marrying the Two Disciplines181
    Large Number of Private Equity/Venture Capital (PE/VC) Investments and Collaborations in the IVD Sector will Fuel Innovation191
    Consolidation of Laboratories across the World191
  Global IVD and CDx Market: Key Technology Trends201
    Emerging Technologies for Cutting Laboratory Costs201
      POCT Technology201
      Automation201
    New Technologies Improve Speed and Accuracy211
      Advanced Technologies Such as Miniaturization of Rapids Tests Expand Use of POCT to Critical Care and Emergency Medicine211
      Growth of Molecular Diagnostics is Facilitating Early Disease Detection211
      Rising Emphasis on Patient Centric, Personalized Medicine to Accelerate Development of Companion Diagnostics211
  Global IVD and CDx Market: Market Drivers221
    Economic Market Drivers221
      Emerging Countries to Play an Important Role in Driving Growth221
      Need to Control Costs at Laboratories to Drive Adoption of New Processes and Instruments221
      Retail Testing Services are Going to Have a Positive Impact on the IVD Market, as Accessibility to the Common Man Improves231
    Technology Market Drivers241
      Growth in New Technologies Such as Molecular Diagnostics and Rapid Tests to Drive IVD Market241
    Regulatory Market Drivers241
      Emergence of Laws for Patent Protection241
      Easing Regulations to Drive Decentralized Testing241
    Social Market Drivers251
      Paradigm Shift towards Preventive Medicine to Drive Growth in Diagnostics for Early Detection and Screening251
      Patient Centric Medicine with Better Informed Consumers Assumes More Significant Role in Managing Their Health251
      Ageing Population to Drive Demand for IVD Tests for Monitoring and Disease Detection251
  Global IVD and CDx Market: Market Restraints251
    Economic Market Restraints251
      Healthcare Budget Deficits in the Majority of Developed Nations to Lead to Rationalization of Testing251
      Pricing Pressures, Low Levels of Reimbursements, Reimbursement Cuts, and Lack of Monetary Incentives for New Tests to Impede Market Growth251
      Local Players for Consumables put Pricing Pressures on International Players in Developing Nations261
    Social Market Restraints261
      Shortage of Skilled Labor a Major Problem for Laboratories261
Global IVD and CDx Market: Market Category Analysis and Forecasts2763
  Clinical Chemistry Market: Market Characterization271
    Global Clinical Chemistry Market, Revenues ($m), 2002 2009272
    Global Clinical Chemistry Market, Revenue Forecasts ($m), 2009 2016292
    Global Clinical Chemistry Market, Key Company Shares (%), 2009311
    Clinical Chemistry Market: Market Drivers321
      The US and the UK Market Segments Are Expected to Drive Growth in the Global Clinical Chemistry Market321
      Need for Greater Productivity and Throughput Gains and Need for Cost Saving Will Drive Segments Such as POC, Rapid Tests, and Automated Analyzers331
      Need for integration will drive purchases of integrated chemical analyzers331
      Ageing population and consequent rise in the incidence of chronic and infectious diseases will continue to drive market growth331
    Clinical Chemistry Market: Market Restraints331
      Market Maturity is Putting Downward Pricing Pressures on Vendors331
      Revised FDA Guidelines and Increased Compliance Expected to Adversely Impact Small Laboratories341
  Immuno Chemistry Market: Market Characterization351
    Global Immuno Chemistry Market, Revenues ($m), 2002 2009352
    Global Immuno Chemistry Market, Revenue Forecasts ($m), 2009 2016372
    Global Immuno Chemistry Market, Key Company Shares (%), 2009392
    Immuno Chemistry Market: Market Drivers411
      The US Immuno Chemistry Market, Followed By Italy Will Drive Growth in Global Immuno Chemistry Market411
      Advances in Molecular Biology, Discovery of New Biomarkers and New Applications to Drive Future Growth421
      Technological Innovations Such as Miniaturization of Biosensors, Microfluidics and Nanotechnology Leading to Development of New, Innovative Immunodiagnostic Rapid Tests421
      Pharmacogenomics and Need for Personalized Testing to Determine Drug Response to Drive Immuno Chemistry Market in the Future431
      Increasing Awareness of Early Screening, Detection and Diagnosis Fuelling Growth431
    Immuno Chemistry Market: Market Restraints431
      Low Reimbursement Rates Hamper the Development and Uptake of New Immunoassays431
  Hematology Market: Market Characterization441
    Global Hematology Market, Revenues ($m), 2002 2009442
    Global Hematology Market, Revenue Forecasts ($m), 2009 2016462
    Global Hematology Market, Key Company Shares (%), 2009481
    Hematology Market: Market Drivers491
      The US, the UK and Italy to Lead Growth in the Global Hematology Market491
      Technological Advancements which aid in Miniaturization, Enhanced Menu Options and Improved Throughput Will Drive the Market501
      Adoption of Automated Analyzers in Small-to-Medium Laboratories Will Lead to Market Growth501
    Hematology Market: Market Restraints501
      Intense Competition Puts Downward Pressure on Profit Margins501
  Histology and Cytology Market: Market Characterization511
    Global Histology and Cytology Market, Revenue ($m), 2002 2009511
    Global Histology and Cytology Market, Revenue Forecasts ($m), 2009 2016521
    Global Histology and Cytology Market, Key Company Shares (%), 2009531
    Histology and Cytology Market: Market Drivers541
      The US and Italy Market Segments Will Drive the Market541
      Advances in Cell/Tissue Staining, Biopsy in Cancer Detection and Diagnosis and Automation Technology Will Drive Market Growth551
    Histology and Cytology Market: Market Restraints551
      New Molecular, Non-Invasive Blood Tests Threaten To Cannibalize Market for Detection of Infectious Diseases551
      Consolidated Market Creates Entry Barriers for Small Players551
  Microbiology Culture Market: Market Characterization561
    Global Microbiology Culture Market, Revenues ($m), 2002 2009562
    Global Microbiology Culture Market, Revenue Forecasts ($m), 2009 2016582
    Global Microbiology Culture Market, Key Company Shares (%), 2009601
    Global Microbiology Culture Market: Market Drivers611
      The US, Itlay and the UK Market Segments Are Expected To Drive Microbiology Market Growth611
      High Prevalence of Infectious Diseases Will Sustain Market Growth in the Future621
      Improved Efficiency, Time Savings and Lack of Skilled Labor Will Lead to Increased Adoption of Automation621
    Global Microbiology Culture Market: Market Restraints621
      Molecular Diagnostics Are Increasingly Replacing the Time-Consuming Process of Bacterial Culture621
  Infectious Immunology Market: Market Characterization631
    Global Infectious Immunology Market, Revenues ($m), 2002 2009631
    Global Infectious Immunology Market, Revenue Forecasts ($m), 2009 2016641
    Global Infectious Immunology Market, Key Company Shares (%), 2009651
    Global Infectious Immunology Market: Market Drivers661
      The US and Italy Hold High Potential for Market Growth661
      Emergence of Highly Infectious Mutant Strains Of Pathogens Will Drive the Demand for Appropriate Diagnostics to Contain the Spread of These Agents671
      New Cases of Humans Infected With Animal Pathogens Will Lead to High Demand for Diagnostic Tests671
    Global Infectious Immunology Market: Market Restraints671
      Reimbursement Systems that do not Provide Incentives to New Tests Will Hold Back Market Growth671
  Genetic Testing Market: Market Characterization681
    Global Genetic Testing Market, Revenues ($m), 2002 2009681
    Global Genetic Testing Market, Revenue Forecasts ($m), 2009 2016691
    Global Genetic Testing Market, Key Company Shares (%), 2009701
    Global Genetic Testing Market: Market Drivers711
      Rapid Adoption of Genetic Testing for Screening Genetic Disorders and High Risk Patients to Drive the Market711
      Advances in Genetics and Proteomics, and Better Understanding of Underlying Genetic Causes of Diseases Will Drive Test Volumes through New Tests721
      Rising Awareness Driven by Direct to Consumer Marketing is Going to Drive the Market in the Future721
      Pharmacogenomic Testing To Play a Significant Role in Driving the Genetics Testing Market721
    Global Genetic Testing Market: Market Restraints721
      Prohibitive Costs for Genetic Tests Likely to Temper High Growth in Demand in the Future721
      Lack of Standardization of Genetic Tests Creates Doubts about the Validity of Tests731
  Global Companion Diagnostics Market: Market Characterization731
    Introduction733
    Selected Companion Diagnostic Assays/Kits761
      AmpliChip CYP450761
      Oncotype Dx761
      MammaPrint761
      Theros Breast Cancer Index761
      HercepTest761
      DakoCytomation EGFR PharmDx771
      PGx Predict:Rituximab771
      PhyzioType PIMS771
      THEROS CancerTYPE ID771
      CupPrint781
      AlloMap gene profile781
      Target GI Test781
      HER2 FISH pharmDx Kit781
      PGx Predict:Rituximab781
      eQ-PCR LC Warfarin Genotyping kit791
    Applications of Companion Diagnostics791
      Optimization of Therapy791
      Increased Safety and Accuracy791
      Rescue drugs failing in the market801
      Preventive rather than Curative Approach801
      Reduce Time, Cost and Failure Rate of Clinical Trials811
    Global Companion Diagnostics Market, Revenue Forecasts ($m), 2009 2016811
    Global Companion Diagnostics Market, Oncology, Revenue Forecasts ($m), 2009-2016822
    Global Companion Diagnostics Market, Infectious Diseases, Revenue Forecasts ($m), 2009-2016842
    Global Companion Diagnostics Market, Cardiovascular Diseases, Revenue Forecasts ($m), 2009-2016861
    Global Companion Diagnostics Market, 2010871
    Global Companion Diagnostics Market: Market Drivers881
      Increase in healthcare costs881
      Patient Compliance881
      Better Regulatory Norms and Validation Procedures881
    Global Companion Diagnostics Market: Market Restraints881
      Payer Reimbursement Issues881
      Ethical Issues891
      Lack of Proper Medical Information Technology891
      Awareness Gap Lack of Physician Education and Awareness about Novel Technologies891
Global IVD and CDx Market: Country Analysis and Forecasts9030
  Global IVD Market: Geographic Trends Analysis901
  Market Characterization, the US, 2002 2016911
    The US IVD and CDx Market, Revenues ($m), 2002 2009912
    The US IVD and CDx Market, Revenues ($m), 2009 2016931
    The US IVD and CDx Market, Market Drivers941
      Ageing Population and Technological Innovation to Drive Testing Volumes941
      Point Of Care and Satellite Laboratory Testing in Non-Traditional, Ambulatory Settings to Gain Increased Focus in the Future941
    The US IVD and CDx Market, Market Restraints941
      Heightened Regulatory Oversight on Personalized Testing Such as Direct to Consumer Genetic Testing to Hamper Growth of Private Players941
  Market Characterization, Europe, 2002 2016951
    The UK IVD and CDx Market951
    The UK IVD and CDx Market, Revenues ($m), 2009 2016962
    Germany IVD and CDx Market, Revenues ($m), 2002 2009982
    Germany IVD and CDx Market, Revenues ($m), 2009 20161002
    France IVD and CDx Market, Revenues ($m), 2002 20091022
    France IVD and CDx Market, Revenues ($m), 2009 20161042
    Italy IVD and CDx Market, Revenues ($m), 2002 20091062
    Italy IVD and CDx Market, Revenues ($m), 2009 20161082
    Spain IVD and CDx Market, Revenues ($m), 2002 20091102
    Spain IVD and CDx Market, Revenues ($m), 2009 20161121
    Europe IVD and CDx Market, Market Drivers1131
      Ageing population to drive growth due to increase in routine testing1131
      Increasing Surveillance for Hospital Acquired Infections to Drive Screening Kits1131
      Consolidation of Laboratories to Create Opportunities in the Laboratory Automation for Managing Pre-Analytical and Post-Analytical Phases1131
    Europe IVD and CDx Market, Market Restraints1141
      Healthcare Budget Deficits in the Majority of European Markets to Continue to Lead to Rationalization of Testing1141
      Purchase Organizations will Leverage their Position to Negotiate Low Cost Contracts, Leading to Thinning Margins1141
  Market Characterization, Japan, 2002 20161151
    Japan IVD and CDx Market, Revenues ($m), 2002 20091152
    Japan IVD and CDx Market, Revenues ($m), 2009 20161171
    Japan IVD and CDx Market, Market Drivers1181
      Ageing Population Will Drive Growth in Developed Countries Such as Japan and Australia, While Population Growth Will Drive Emerging Economies1181
      Increased Technology Adoption will be a Uniform Trend Driving the Sales of IVD Instruments in the Future1181
    Japan IVD and CDx Market, Market Restraints1191
      Laboratory Consolidation to Put a Further Squeeze on the IVD Margins in Japan and Australia1191
      Local Players Give Tough Competition to International Players by Offering Cheap Products1191
Global IVD and CDx Market: Strategic Competitive Assessment12024
  Key Market Participants1201
    F. Hoffmann-La Roche Ltd1201
      Company Overview1201
      Deals Landscape1211
      Pipeline Product Portfolio1222
    Siemens Medical Solutions USA, Inc.1241
      Company Overview1241
      Deals Landscape1241
      Pipeline Product Portfolio1251
    Abbott Laboratories1261
      Company Overview1261
      Deals Landscape1271
      Pipeline Product Portfolio1281
    Beckman Coulter, Inc.1291
      Company Overview1291
      Deals Landscape1301
      Pipeline Product Portfolio1311
    bioMerieux Sa1321
      Company Overview1321
      Deals Landscape1331
      Pipeline Product Portfolio1341
    Ortho-Clinical Diagnostics1341
      Company Overview1341
      Deals Landscape1341
      Pipeline Product Portfolio1351
    Becton, Dickinson and Company1351
      Company Overview1351
      Deals Landscape1361
      Pipeline Product Portfolio1361
    Bio-Rad Laboratories, Inc.1371
      Company Overview1371
      Deals Landscape1371
    Roche Diagnostics1371
      Overview1371
      Deals Landscape1381
      Pipeline1391
    Epigenomics AG1391
      Overview1391
      Deals Landscape1401
      Pipeline1401
    Qiagen N.V1401
      Overview1401
      Deals Landscape1411
      Pipeline1411
    Dako Denmark A/S1411
      Overview1411
      Deals Landscape1421
      Pipeline1421
    Celera Corporation1421
      Overview1421
      Deals Landscape1431
      Pipeline1431
Global IVD and CDx Market: Product Pipeline Analysis14411

Table Of Contents

GBI Research Reports—GBI Research covers worldwide markets and issues, supplies actionable data and forecasts and is driven by industry leaders' insights. GBI Research provides a broad spectrum of reports across the healthcare and energy industries and its online offering is easy to navigate - a comprehensive resource for business information needs.

About the Author


Cite this Report

  
MLA:
GBI Research Reports. "In-vitro and Companion Diagnostics Industry - 2010 Yearbook" Jan 21, 2011. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GBI-Research-Reports/In-vitro-and-Companion-Diagnostics-Industry-2010-Yearbook-2115-149>
  
APA:
GBI Research Reports. (2011). In-vitro and Companion Diagnostics Industry - 2010 Yearbook Jan 21, 2011. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GBI-Research-Reports/In-vitro-and-Companion-Diagnostics-Industry-2010-Yearbook-2115-149>
  
US$ 3,500.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.